Sleep Disorder Drug Discovery Service
After decades of accumulation, Creative Biolabs has developed into a pioneer in the field of neuroscience. With a comprehensive platform and dedicated scientists, we are confident in providing standard and custom in vivo and in vitro assays to accelerate preclinical sleep disorders drug discovery.
Introduction to Sleep Disorder
Sleep has long been considered a sophisticated biological process. While sleeping, the body and brain are not at rest, they do a lot of pivotal work and help keep us healthy. Therefore, physical and mental health and daily activities can be severely impacted when sleep is problematic. Some of the hallmarks of sleep disorder include lethargy, irregular breathing, and increased movement during sleep. As we all know, narcolepsy and insomnia are typical sleep troubles in daily life. A variety of factors are closely related to sleep disorders. For instance, various diseases, such as lung disease, anxiety, and depression can adversely affect sleep. In addition to this, drugs and genetics are also closely related to sleep problems. Notably, caffeine and alcohol, irregular schedules, and aging also contribute to the disorder. Sleep disorders can usually be improved with regular sleep habits. Chronic insomnia is often treated with a combination of sleep medication and behavioral techniques, such as cognitive behavioral therapy. Also, some antidepressants are valid to treat insomnia.
Fig.1 Various neuropsychiatric disorders that may coexist with narcolepsy. (BaHammam, 2020)
Our Capabilities in Sleep Disorder Drug Discovery
As a leader in drug discovery for neurological diseases, Creative Biolabs is confident in accelerating drug discovery research by using our industry-leading portfolio of drug discovery solutions. Our integrated approach has been successful in delivering timely and cost-effective solutions and generating new intellectual property. A wide range of in vivo and in vitro models as well as characteristic assays are the foundation of our high-quality service.
Fig.2 Sleep disorder drug discovery service. (Creative Biolabs)
Various Animal Models
Despite many differences in sleep between animals and humans, there are many similarities between humans and rodents in sleep homeostasis regulation, sensitivity to endogenous and environmental factors, and responses to wake-promoting and hypnotic drugs. This is the premise of using animal models to study sleep disorders. In short, animal models are essential to screen potential target compounds. At Creative Biolabs, animal models for prevalent sleep disorders are available, such as animal models of insomnia, narcolepsy, restless legs syndrome, and sleep apnea.
Featured Cellular Models
- Primary Neuronal Cell Culture Models
- Human iPSC Derived Neuronal Cell Culture Models
- Organotypic Brain Slice Models
What Can We Do?
- Drug Combination Assay
- Functional Assays
- Toxicity Assays
- Neuronal Plasticity Assay
- Behavioral Testing Services
Our experienced scientists with strong expertise in sleep disorders drug discovery are committed to advancing your most promising preclinical drug screens. Specializing in standard and custom in vivo and in vitro assays, we focus on providing our clients with flexible and cost-effective solutions. If you have any difficulties with your drug development project, please feel free to contact us to discuss your project.
Reference
- BaHammam, A. S.; et al. Neuropsychiatric correlates of narcolepsy. Current Psychiatry Reports. 2020, 22(8): 1-11.

- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)